A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL
Clinical trial NCT07607925 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07607925
- Sponsor
- GlaxoSmithKline
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-12
- Primary completion
- 2029-09-24
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.